Margin dodolan resik: Pacific Biosciences of California (PACB)

PacBio Corp - logo grafis emiten PACB

Pacific Biosciences operates sterile plants and R&D centers in the US for the assembly of sequencing instruments. Revenues are based on the sale of high-precision systems, software, and consumables. The business's net margin efficiency demonstrates profit dynamics, where -81.30 forms the current metric indicator. Simultaneously, the company is minimizing plastic waste and optimizing energy costs across its laboratories.

PacBio Corp (PACB) - Margin dodolan perusahaan saka 04.07.2022 nganti 19.11.2026

Rincian metrik komprehensif lan analitis Pacific Biosciences of California (PACB)

Analisis dhasar perusahaan:PacBio Corp - PACB
Produk asil prodhuksi Pacific Biosciences of California, Inc.

The high-tech production of DNA sequencing systems by Pacific Biosciences (PACB) utilizing robotic lines and machine vision requires significant capital expenditures. Net margin determines the portion of revenue remaining after all expenses, allowing an investor to assess the real profitability of each product unit by analyzing the business's net marginal efficiency to identify cycle phases and risks of a future correction.

Analisis perusahaan pesaing

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX